Molecular Cancer Therapeutics CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ausserlechner, M. J.
Right arrow Articles by Kofler, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ausserlechner, M. J.
Right arrow Articles by Kofler, R.
Mol Cancer Ther. 2006;5:1927-1934
© 2006 American Association for Cancer Research

Research Articles: Targets

A retroviral expression system based on tetracycline-regulated tricistronic transactivator/repressor vectors for functional analyses of antiproliferative and toxic genes

Michael J. Ausserlechner1, Petra Obexer3, Andrea Deutschmann1,3, Kathrin Geiger3 and Reinhard Kofler2,3

1 Molecular Biology Research Laboratory, Department of Pediatrics, Medical University Innsbruck; 2 Division of Molecular Pathophysiology, Biocenter, Medical University Innsbruck; and 3 Tyrolean Cancer Research Institute, Innsbruck, Austria

Requests for reprints: Michael J. Ausserlechner, Molecular Biology Research Laboratory, Pediatric Department, Medical University Innsbruck, Innrain 66, A-6020 Innsbruck, Austria. Phone: 43-512-504-27748; Fax: 43-512-504-27750. E-mail: michael.j.ausserlechner{at}uibk.ac.at

Establishment of stably transfected mammalian cells with conditional expression of antiproliferative or proapoptotic proteins is often hampered by varying expression within bulk-selected cells and high background in the absence of the inducing drug. To overcome such limitations, we designed a gene expression system that transcribes the tetracycline-dependent rtTA2-M2-activator, TRSID-silencer, and selection marker as a tricistronic mRNA from a single retroviral vector. More than 92% of bulk-selected cells expressed enhanced green fluorescent protein or luciferase over more than three orders of magnitude in an almost linear, dose-dependent manner. To functionally test this system, we studied how dose-dependent expression of p27Kip1 affects proliferation and viability of SH-EP neuroblastoma cells. Low to moderate p27Kip1 expression caused transient G0-G1 accumulation without reduced viability, whereas high p27Kip1 levels induced significant apoptosis after 72 hours. This proves that this expression system allows concentration-dependent analysis of gene function and implicates p27Kip1 as a critical regulator of both proliferation and apoptosis in SH-EP neuroblastoma cells. [Mol Cancer Ther 2006;5(8):1927–34]


Grant support: Austrian Science Fund (SFB-F021) and P18571, the Children Cancer Society of Tyrol and Vorarlberg, the Kinderkrebshilfe Südtirol Regenbogen, the Children's Cancer Research Institute, SVP-Women Organisation, the OeNB Anniversary Fund Project 11436, Provita Kinderleukämiestiftung, MFF-Tirol, Tiroler Landeskrankenanstalten Ges.m.b.H., the Tyrolean Cancer Society, and the Department of Health-Care, Autonomy of South Tyrol.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Note: M.J. Ausserlechner and P. Obexer contributed equally to this work.

4 Unpublished data.

Received 11/30/05; revised 6/11/06; accepted 6/22/06.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
F. R. Santer, B. Moser, G. A. Spoden, P. Jansen-Durr, and W. Zwerschke
Human papillomavirus type 16 E7 oncoprotein inhibits apoptosis mediated by nuclear insulin-like growth factor-binding protein-3 by enhancing its ubiquitin/proteasome-dependent degradation
Carcinogenesis, December 1, 2007; 28(12): 2511 - 2520.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.